UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Income Statement [Abstract]
Revenues	$ 4,905,420	$ 1,490,100	$ 8,423,195	$ 2,790,200
Operating expenses
General and administrative	942,650	363,230	1,752,395	637,776
Salaries and wages	2,243,222	717,032	4,306,520	1,444,773
Rent expense	767,114	274,130	1,506,915	539,262
Professional fees	419,701	301,132	775,813	451,682
Management fees	120,000		120,000
Depreciation and amortization	203,265	112,086	399,486	223,292
Total operating expenses	4,695,952	1,767,610	8,861,129	3,296,785
Operating income (loss)	209,468	(277,510)	(437,934)	(506,585)
Other Income (expense)
Other income	91		172,331
Interest income	466	523	1,685	1,098
Interest expense	(324,846)	(106,914)	(617,703)	(200,100)
Amortization of debt discount	(160,088)	(75,240)	(289,970)	(138,402)
Foreign exchange movements	(34,054)	(6,134)	(34,811)	4,511
Net loss before income taxes	(308,963)	(465,275)	(1,206,402)	(839,478)
Income taxes	13,434		25,776
Net loss	(295,529)	(465,275)	(1,180,626)	(839,478)
Net loss attributable to non-controlling interest		101,842		101,842
Net loss available to common shareholders of Ethema Health Corporation	$ (295,529)	$ (363,433)	$ (1,180,626)	$ (737,636)
Loss per share - Basic	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Loss per share - Diluted	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Weighted average common shares outstanding - Basic	7,726,283,805	3,729,053,805	7,727,044,794	3,729,053,805
Weighted average common shares outstanding - Diluted	7,726,283,805	3,729,053,805	7,727,044,794	3,729,053,805